menu
The virtual clinical trial service providers market is estimated to be worth USD 12 billion in 2050- Roots Analysis'
The virtual clinical trial service providers market is estimated to be worth USD 12 billion in 2050- Roots Analysis'
Conventional clinical trials are fraught with inefficient patient management and data handling practices, which has prompted trial sponsors to implement digital innovation and virtual technologies across different aspects of drug development.

Roots Analysis is pleased toannounce the publication of its recent study, titled, “VirtualClinical Trial Service ProvidersMarket, 2020-2050

 

The report featuresan extensive study of the current landscape of industry players that areoffering various types of innovative clinical research platforms / solutions tothe pharmaceutical and life sciences industries. Amongst other elements, thereport features:

§ An overview of thecurrent market landscape of companies offering solutions for virtual clinicaltrials, featuring information on year of establishment, geographical location,company size and types of services offered (study start-up, patient enrollment,drug logistics, data collection and analysis, and patient retention).

§  Brief profiles ofcompanies offering solutions for virtual clinical trials, featuring informationon their year of establishment, respective headquarters, company size, keyexecutives, service / technology portfolio, recent developments and an informedfuture outlook.

§  A case study on theinitiatives of big pharma players related to virtual clinical trials, offeringinsights on such clinical studies that have been conducted / planned by theaforementioned players, along with details on associated constraints and thefuture plans of players engaged in this domain.

§  An analysis of thefunding and investments made in the domain, in the period between 2014 and 2020(till November), including seed financing, venture capital financing,debt financing, grants, capital raised from IPOs and subsequent offerings, atvarious stages of development in companies that are engaged in this field,based on several parameters, such as number of funding instances, amountinvested, type of funding, leading players and investors, and geographicalanalysis.

§  An analysis of thepartnerships and collaborations inked in the domain, in the period between 2014and 2020 (till November), based on several parameters, such as year ofpartnership, type of partnership, application mentioned in agreement, targettherapeutic area mentioned in the agreement, type of partner, most activeplayers and geographical analysis.

§  A detailed studyhighlighting the key differences between traditional and virtual CROs and anelaborate road map, presenting the requirements for a traditional CRO totransition to a virtual CRO business model.

§  A brief case studyhighlighting the impact of COVID-19 pandemic on virtual clinical trial serviceproviders market.

§  A detailed analysisof completed, ongoing and planned virtual clinical trials, based on multipleparameters, such as trial registration year, trial phase, trial status, type ofsponsor / collaborator, target therapeutic area, trial design, top sponsor,geographical location of trial and enrolled patient population.

§  A detailed marketforecast, featuring analysis of the current and projected future opportunityacross key market segments (listed below)

§ Therapeutic Area

§ CardiovascularDisorders

§ CNS Disorders

§ Infectious Disorders

§ Metabolic Disorders

§ Oncological Disorders

§ Respiratory Disorders

§ Other Disorders

 

§ Phase of Development

§ Phase I

§ Phase II

§ Phase III

§ Phase IV

 

§ Key GeographicalRegions 

§ North America

§ Europe

§ Asia-Pacific

§ Rest of theWorld 

 

Key companies covered in the report

§ Cambridge Cognition

§ Center Point Clinical Services

§ eClinicalHealth

§ IQVIA

§ Mytrus (Medidata Solutions)

§ PanAmerican Clinical Research

§ Science 37

§ VirTrial

 

For more information, pleaseclick on the following link:

https://www.rootsanalysis.com/reports/virtual-clinical-trial-service-provides-market.html

 

Other RecentOfferings

1.      PatientRecruitment and Retention Services Market (2nd Edition) by TherapeuticAreas (Cardiovascular Diseases, Oncological Disorders, Infectious Diseases, CNSDisorders, Respiratory Disorders, Hematological Disorders and Others), PatientRecruitment Steps (Pre-screening and Screening), Trial Phases (Phase I, PhaseII, Phase III and Phase IV), and Key Geographies (North America, Europe,Asia-Pacific, Latin America, MENA, and RoW) – Industry Trends and GlobalForecasts, 2021-2030

2.      DigitalSolutions for Biomarkers Market by Content (Standalone Software Solutionsand Combination Offerings), Purpose (Diagnosis, Early Screening, Monitoring,and Predictive Insights), Type of Biomarker (Cognitive, Idiosyncratic,Physiological, Vocal, and Other Biomarkers), Therapeutic Area, Business Model,and by Key Geographical Regions (North America, Europe, Asia-Pacific, MiddleEast and North Africa, and Rest of the World): Industry Trends and GlobalForecasts, 2021-2030

3.      Pharmaceuticaland Life Sciences Real World Evidence (2nd Edition), 2021-2030:Distribution by Applications (Early Stage Research, Clinical Development,Regulatory Approval, Pricing / Reimbursement, Post-Approval Studies), RealWorld Data Sources (Medical Claims, Clinical Trials, Clinical Setting, PatientPowered and Others), Key Therapeutic Areas, and Geography (North America,Europe, Asia-Pacific, Latin America, Middle East and North Africa, and Rest ofthe World)

 

About Roots Analysis

Roots Analysis is oneof the fastest growing market research companies, sharing fresh and independentperspectives in the bio-pharmaceutical industry. The in-depth research,analysis and insights are driven by an experienced leadership team which hasgained many years of significant experience in this sector. If you’d like helpwith your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots AnalysisPrivate Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com